Fair Value Calculator Fair Value Calculator
EN DE

RELICTEC (RELICTEC) Fair Value & Analysis

IN · Market cap ₹385M

R RELICTEC RELICTEC · BSE
Price₹68.83
Fair Value₹23.78
Upside-65.5%
Quality33/100
Watch RELICTEC for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range ₹15.70 – ₹29.73

Fair value as of: Jul 5, 2026

From 1 valuation models · updated today

Share price −7.6% over the past month.

Price vs Fair Value (12 months)

₹89.69 ₹62.25 Fair Value ₹23.78 Jul 2025 Jul 2026

12‑month range ₹62.25 – ₹89.69 · fair‑value band ₹15.70 – ₹29.73 · the ₹68.83 price screens above the ₹23.78 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

RELICTEC (RELICTEC) currently trades at ₹68.83, while our model-based Fair Value estimate is ₹23.78 — implying the stock looks roughly 65.5% overvalued today. We read business quality at 33/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at ₹33.2M. Revenue grew 58.9% year over year. It earns a return on equity of -65.4%. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹15.70 (bear case) to ₹29.73 (bull case); at ₹68.83, the current price sits above that range. The share trades about 27% below its 52-week high and 21% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹33.2M
Revenue growth (YoY) +58.9%
Net margin -162%
Return on equity -65.4%
Free cash flow −₹169M FY2026
Operating margin -137%
More key figures
EPS (TTM) ₹-13.19
EPS growth (YoY) -27.5%

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

RELICTEC reported revenue of ₹26.7M in FY2026 versus ₹17.2M in FY2022, a compound +11.6%/yr. Reported net income was −₹53.7M in FY2026.

Revenue +11.6%/yr
FY22 ₹17.2M
FY23 ₹14.5M
FY24 ₹15.3M
FY25 ₹19.8M
FY26 ₹26.7M
Net income
FY22 ₹4.3M
FY23 ₹2.3M
FY24 −₹9.0M
FY25 −₹14.0M
FY26 −₹53.7M

Is RELICTEC fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "RELICTEC Fair Value". https://www.fairvalue-calculator.com/stock/RELICTEC

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is RELICTEC (RELICTEC) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹23.78 versus a price of ₹68.83 — about −65% (overvalued). Model-based estimate, not financial advice.
What is the fair value of RELICTEC?
Our model-based fair value for RELICTEC is ₹23.78 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹68.83.
What is the quality score of RELICTEC?
RELICTEC has a Quality Score of 33/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of RELICTEC (RELICTEC)?
RELICTEC reported trailing-twelve-month revenue of about ₹33.2M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of RELICTEC?
The net profit margin of RELICTEC is about -161.9%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.